Gene · 2103
ESRRB: estrogen related receptor beta
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. ESRRB: estrogen related receptor beta. Genes, record 2103. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/2103
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| O95718 | Steroid hormone receptor ERR2 | 433 | 3 | Ensembl, GeneID, HGNC |
Source UniProt
Patents19
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| JP 2026004568 A | 2026-01-14 | 45296 | O95718 | Espacenet |
| JP 2025147176 A | 2025-10-06 | 14944 | O95718 | Espacenet |
| JP 2025032204 A | 2025-03-11 | 27953 | O95718 | Espacenet |
| JP 2025028160 A | 2025-02-28 | 14944 | O95718 | Espacenet |
| KR 1020250010750 A | 2025-01-21 | 14944 | O95718 | Espacenet |
| EP 4461818 A2 | 2024-11-13 | 27953 | O95718 | Espacenet |
| JP 2024109657 A | 2024-08-14 | 14783 | O95718 | Espacenet |
| JP 2023058610 A | 2023-04-25 | 27953 | O95718 | Espacenet |
| US 11446398 B2 | 2022-09-20 | 28270 | O95718 | Espacenet |
| JP 2022524081 A | 2022-04-27 | 131241 | O95718 | Espacenet |
1 to 10 of 19
See all 19 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants1,602
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | ESRRB papers | Newest fiscal year |
|---|---|---|---|
| P30CA051008 | Georgetown University Lombardi Comprehensive Cancer Center Support Grant | 8 | 2025 |
| T32CA009686 | Training Grant In Tumor Biology | 7 | 2025 |
| P30CA008748 | Cancer Center Support Grant | 6 | 2025 |
| P30CA014051 | Cancer Center Support (Core) Grant | 4 | 2025 |
| P30CA021765 | Cancer Center Support Grant (CCSG) | 4 | 2025 |
| P30DK063491 | Diabetes Research Center (DRC) | 4 | 2025 |
| P30DK084567 | Mayo Center for Cell Signaling in Gastroenterology | 4 | 2025 |
| P30CA014195 | Cancer Center Support Grant (CCSG) | 3 | 2025 |
| P30CA014520 | UW Comprehensive Cancer Center Support | 3 | 2025 |
| P30CA016086 | Cancer Center Support Grant | 3 | 2025 |
1 to 10 of 1,602Source NIH's project files
See all 1,602 nih grantsPapers2,018
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A non-canonical androgen signaling pathway drives microglial activation and tau pathology in females. | Res Sq | 2026 | 42523519 | PubTator, text mining | PubMed |
| Coregulatory Networks Remodel the Disease-Specific Functions of Orphan Nuclear Receptor TR4. | Cells | 2026 | 42439692 | PubTator, text mining | PubMed |
| Decoding stage-specific functions of PRC2 in early embryogenesis uncovers roles in preimplantation development and primordial germ cell fate. | Nat Cell Biol | 2026 | 42432166 | PubTator, text mining | PubMed |
| Pharmacology of estrogen-related receptors (ERRs) agonists. | RSC Chem Biol | 2026 | 42256350 | PubTator, text mining | PubMed |
| Cdk1-phosphorylated Nur77 accumulates at the centrosome during mitosis to regulate the Cep192-PLK1 signaling axis. | Cell Death Dis | 2026 | 42236697 | PubTator, text mining | PubMed |
| Mechanisms coordinating exit from the stem cell state in mammals. | Genes Dev | 2026 | 42156139 | PubTator, text mining | PubMed |
| Nur77 Is Associated With Polyfunctional Properties in Virus-Specific Human CD8+ T Cells. | Eur J Immunol | 2026 | 42117214 | PubTator, text mining | PubMed |
| Screening for differentially expressed genes in retinoblastoma gene chips through the GEO database and validation in clinical settings. | Int J Ophthalmol | 2026 | 42039963 | PubTator, text mining | PubMed |
| 3D-super-enhancers are condensate-associated cis-regulatory communities. | Nucleic Acids Res | 2026 | 41797539 | PubTator, text mining | PubMed |
| Construction and initial validation of key gene network for progesterone resistance in endometrial cancer based on genome-wide CRISPR screening. | Sci Rep | 2026 | 41775739 | PubTator, text mining | PubMed |
1 to 10 of 2,018
See all 2,018 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/2103
GET https://conductscience.org/api/genes/v1/2103/patents